Company intelligence / Profile preview

Paloma Health

Multiple, USA

Ownership: Private
Development stage: Other

Overview

Paloma Health delivers telehealth management and personalized care to hypothyroid and related endocrine patients, showing 92% symptom relief after 3 months of treatment; offers diagnostic kits, virtual visits, and medication management

Therapeutic areas: EndocrinologyWomen's Health
Modalities: Small moleculeBiologicHormone
Industry: Non-Academic Healthcare

Partnerships

Acella PharmaceuticalsAlora Pharmaceuticals

Beyond the preview

Go deeper on Paloma Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paloma Health.

Explore the full profile